Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor

Vaccine

Volumn 25, Issue 49, 2007, Pages 8209-8219

  Du, Yijun ^a   Jiang, Ping ^a   Li, Yufeng ^a   He, Hairong ^b   Jiang, Wenming ^a   Wang, Xinglong ^a   Hong, Weibin ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b Qianyuanhao Biological Co Ltd   (China)

Author keywords

Epitope; Foot and mouth disease virus; Granulocyte macrophage colony stimulating factor (GMCSF); Recombinant adenovirus

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; PROTEIN VP1; RAD GMCSF VP1; RAD GMCSF VPE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; IMMUNIZATION; INOCULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SWINE; VIRUS DETECTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELL LINE; CRICETINAE; FEMALE; FOOT-AND-MOUTH DISEASE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GUINEA PIGS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; SWINE; T-LYMPHOCYTES; VIRAL VACCINES;

EID: 36048936939     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.062     Document Type: Article

References (52)

1. Belsham G.J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family, aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol 60 (1993) 241-260
2. Mason P.W., Grubman M.J., and Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res 91 1 (2003) 9-32
3. Bachrach H.L., Moore D.M., McKercher P.D., and Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol 115 6 (1975) 1636-1641
4. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., et al. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214 4525 (1981) 1125-1129
5. Saiz M., Nunez J.I., Jimenez-Clavero M.A., Baranowski E., and Sobrino F. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 4 11 (2002) 1183-1192
6. Kupper H., Keller W., Kurz C., Forss S., Schaller H., Franze R., et al. Cloning of cDNA of major antigen of foot-and-mouth disease virus and expression in E. coli. Nature 289 (1981) 555-559
7. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Suteliffe J.G., Lerner R.A., et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-35
8. Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 10 (1992) 1022-1026
9. Van Lierop M.J.C., Van Maanen K., Meloen R.H., Rutten V.P.M.G., De Jong M.A.C., and Hensen E.J. Proliferative lymphocyte response to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75 (1992) 406-413
10. Parry N.R., Fox G., Rowlands D., Brown F., Fry E., Acharya R., et al. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature (London) 347 (1990) 569-572
11. Collen T., Dimarchi R., and Doel T.R. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146 (1991) 749-755
12. Doel T.R. FMD vaccines. Virus Res 91 (2003) 81-89
13. Barteling S.J., and Vreeswijk J. Developments in foot-and-mouth disease vaccines. Vaccine 9 (1991) 75-88
14. King A.M., Underwood B.O., McCahon D., Newman J.W., and Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK. Nature 293 (1981) 479-480
15. Valledor A.F., Borras F.E., Cullen-Young M., and Celada A. Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol 63 (1998) 405-417
16. Heufler C., Koch F., and Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167 (1988) 700-705
17. Armitage J.O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92 (1998) 4491-4508
18. Disis M.L., Bernhard H., Shiota F.M., Hand S.L., Gralow J.R., Huseby E.S., et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88 (1996) 202-210
19. Kusakabe K., Xin K.Q., Katoh H., Sumino K., Hagiwara E., Kawamoto S., et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol 164 (2000) 3102-3111
20. Lutz M.B., Assmann C.U., Girolomoni G., and Ricciardi-Castagnoli P. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line. Eur J Immunol 26 (1996) 586-594
21. Samanci A., Yi Q., Fagerberg J., Strigard K., Smith G., Ruden U., et al. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 47 (1998) 131-142
22. Robinson H.L., Montefiori D.C., Villinger F., Robinson J.E., Sharma S., Wyatt L.S., et al. Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine. Virology 352 (2006) 285-294
23. Tarr P.E., Lin R., Mueller E.A., Kovarik J.M., Guillaume M., and Jones T.C. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 14 (1996) 1199-1204
24. Kumar S., Villinger F., Oakley M., Aguiar J.C., Jones T.R., Hedstrom R.C., et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol Lett 81 (2002) 13-24
25. Weiss W.R., Ishii K.J., Hedstrom R.C., Sedegah M., Ichino M., Barnhart K., et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 161 (1998) 2325-2332
26. Cedillo-Barron L., Foster-Cuevas M., Belsham G.J., Lefevre F., and Parkhouse R.M. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82 (2001) 1713-1724
27. Li Y., Aggarwal N., Takamatsu H., Sterling C.M., Voyce C., and Barnett P.V. Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 24 (2006) 4602-4606
28. Nandi S., Suryanarayana V.V.S., Banumathi N., and Sen A.K. Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEF. Comp Immunol Microbiol Infect Dis 20 (1997) 95-99
29. Jiang W., Jiang P., Li Y., Tang J., Wang X., and Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet Immunol Immunopathol 113 (2006) 169-180
30. Maliszewski C.R., Schoendorn M.A., and Ceretti D.P. Bovine GM-CSF: molecular cloning and biological activity of the recombinant protein. Mol Immunol 25 (1988) 843-850
31. De Logu A., Loy G., Luisa Pellerano M., Bonsignore L., and Laura Schivo M. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res 48 (2000) 177-185
32. Zheng M., Jin N.Y., Zhang H.Y., Jin M.L., Lu H.J., Ma M.X., et al. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J Virol Methods 136 (2006) 230-237
33. Wang C.Y., Chang T.Y., Walfield A.M., Ye J., Shen M., Chen S.P., et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20 (2002) 2603-2610
34. Kaur R., Sachdeva G., and Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis 185 (2002) 1-12
35. Shieh J.J., Liang C.M., Chen C.Y., Lee F., Jong M.H., Lai S.S., et al. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Vaccine 19 (2001) 4002-4010
36. Zhang H.-Y., Sun S.-H., Guo Y.-J., Zhou F.-J., Chen Z.-H., Lin Y., et al. Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 21 (2003) 4704-4707
37. Wigdorovitz A., Carrillo C., Dus Santos M.J., Trono K., Peralta A., Gomez M.C., et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255 (1999) 347-353
38. Balamurugan V., Renji R., Venkatesh G., Reddy G.R., Nair S.P., Ganesh K., et al. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris. Arch Virol 150 (2005) 967-979
39. Berinstein A., Tami C., Taboga O., Smitsaart E., and Carrillo E. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 18 (2000) 2231-2238
40. Qian P., Li X.-M., Jin M.-L., Peng G.-Q., and Chen H.-C. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 22 (2004) 2129-2136
41. Mayr G.A., Chinsangaram J., and Grubman M.J. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263 (1999) 496-506
42. Moraes M.P., Mayr G.A., Mason P.W., and Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20 (2002) 1631-1639
43. Pacheco J.M., Brum M.C., Moraes M.P., Golde W.T., and Grubman M.J. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337 2 (2005) 205-209
44. Shi X.-J., Wang B., Zhang C., and Wang M. Expression of BoIFN-γ and foot and mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine 24 (2006) 82-89
45. Shi X.-J., Wang B., and Wang M. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine 25 (2007) 1257-1264
46. Li G.J., Chen W.Z., Yan W.Y., Zhao K., Liu M.Q., Zhang J., et al. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or β-galactosidase as a carrier of immunogenic epitopes. Virology 328 (2004) 274-281
47. Bona C., Brumeane T., and Zaghouani H. Immunogenicity of microbial peptides grafted in self immunoglobulin molecules. Cell Mol Biol 40 (1994) 21-30
48. Syred A.D., Highfield P.E., Rowlands D.J., and Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330 (1987) 381-384
49. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F., and Rowlands D.J. Non-responsive-ness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (London) 330 (1987) 168-170
50. Collen T., Pullen L., and Doel T.R. T-cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol 70 (1989) 395-403
51. Sanz-Parra A., Blasco R., Sobrino F., and Ley V. Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Arch Virol 143 (1998) 389-398
52. Eblé P.L., de Bruin M.G., Bouma A., van Hemert-Kluitenberg F., and Dekker A. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Vaccine 24 (2006) 1274-1281